Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-14004880Phase 4Recruiting
Phase 4, open-label trial of dexmedetomidine (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Delirium, Unpleasant ICU experience and 1 more. Started Aug 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-14004880.